Movement does not promote recovery of motor output following acute experimental muscle pain by Schabrun, Siobhan M. et al.
 
  
 
Aalborg Universitet
Movement does not promote recovery of motor output following acute experimental
muscle pain
Schabrun, Siobhan M.; Palsson, Thorvaldur Skuli; Thapa, Tribikram; Graven-Nielsen,
Thomas
Published in:
Pain Medicine
DOI (link to publication from Publisher):
10.1093/pm/pnx099
Publication date:
2018
Document Version
Accepted author manuscript, peer reviewed version
Link to publication from Aalborg University
Citation for published version (APA):
Schabrun, S. M., Palsson, T. S., Thapa, T., & Graven-Nielsen, T. (2018). Movement does not promote recovery
of motor output following acute experimental muscle pain. Pain Medicine, 19(3), 608–614.
https://doi.org/10.1093/pm/pnx099
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us at vbn@aub.aau.dk providing details, and we will remove access to
the work immediately and investigate your claim.
For Review
 O
nly
 
 
 
 
 
 
MOVEMENT DOES NOT PROMOTE RECOVERY OF MOTOR 
OUTPUT FOLLOWING ACUTE EXPERIMENTAL MUSCLE PAIN 
 
 
Journal: Pain Medicine 
Manuscript ID PME-ORR-Jul-16-483.R1 
Manuscript Type: Original research 
Date Submitted by the Author: 23-Feb-2017 
Complete List of Authors: Schabrun, Siobhan; University of Western Sydney, School of Science and 
Health 
Palsson, Thovaldur; Aalborg University, Laboratory for Experimental Pain 
Research, Centre for Sensory-Motor Interaction, Department of Health 
Science and Technology 
Thapa, Tribikram; University of Western Sydney, School of Science and 
Health 
Graven-Nielsen, Thomas; Aalborg University, Laboratory for Experimental 
Pain Research, Centre for Sensory-Motor Interaction, Department of Health 
Science and Technology 
Keywords: 
Transcranial magnetic stimulation, motor activity, recovery, corticomotor 
output, experimental muscle pain 
  
 
 
Official Journal of the American Academy of Pain Medicine
Pain Medicine
For Review
 O
nly
 1 
MOVEMENT DOES NOT PROMOTE RECOVERY OF MOTOR OUTPUT FOLLOWING 
ACUTE EXPERIMENTAL MUSCLE PAIN 
Siobhan M Schabrun PhD
1
, Thorvaldur S Palsson PhD
2
, Tribikram Thapa MSc (PT)
1
, Thomas 
Graven-Nielsen DMSc, PhD
2,* 
 
1 
Western Sydney University, Brain Neuroplasticity and Rehabilitation Unit (BRAiN-u), School of 
Science and Health, Locked bag 1797 Penrith, NSW 2751, Australia.  
2 
Laboratory for Musculoskeletal Pain and Motor Control, Center for Neuroplasticity and Pain 
(CNAP), Department of Health Science and Technology, Faculty of Medicine, Aalborg 
University, Aalborg, Denmark. 
 
 
Running head: Motor output recovery following experimental pain 
 
Corresponding author:  
Professor Thomas Graven-Nielsen, DMSc, PhD.  
Center for Neuroplasticity and Pain (CNAP) 
SMI, Department of Health Science and Technology 
Faculty of Medicine 
Aalborg University 
Frederik Bajers Vej 7D-3 
Aalborg E 9220 
Denmark.  
Tel +45-9940-9832  
Fax +45-9815-4008  
E-mail: tgn@hst.aau.dk  
 
Funding sources and disclosures: SMS receives salary support from the National Health and 
Medical Research Council of Australia (1105040). The Center for Neuroplasticity and Pain (CNAP) 
is supported by the Danish National Research Foundation (DNRF121). 
  
Page 1 of 18
Official Journal of the American Academy of Pain Medicine
Pain Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review
 O
nly
 2 
ABSTRACT  
Objective: To examine the effect of motor activity on the magnitude and duration of altered 
corticomotor output following experimental muscle pain. 
Design: Experimental, pre-post test 
Setting: University laboratory 
Subjects: Twenty healthy individuals.  
Methods: Participants were randomly allocated to a Rest or Movement group. The Rest group sat 
quietly, without moving for the duration of the experiment. The Movement group repeated a 
unimanual pattern of five sequential keystrokes as quickly and as accurately as possible 
immediately following the resolution of pain. Pain was induced into the right extensor carpi radialis 
brevis muscle by a bolus injection of 0.5ml hypertonic saline. Corticomotor output was assessed as 
motor evoked potentials in response to transcranial magnetic stimulation before, immediately after, 
and at 10, 20 and 30 minutes following pain resolution. Pain intensity was recorded every 30 
seconds using an 11-point numerical rating scale. 
Results: There was no difference in peak pain intensity (P<0.09) or duration (P<0.2) between 
groups. Corticomotor output was reduced in both groups (P<0.002) at 10 min (P<0.002), 20 min 
(P<0.02), and 30 min (P<0.037) following the resolution of pain relative to baseline. There was no 
difference between groups at any time-point. 
Conclusions: Performance of motor activity immediately following the resolution of acute muscle 
pain did not alter the magnitude or duration of corticomotor depression. Understanding 
corticomotor depression in the post-pain period and what factors promote recovery has relevance 
for clinical pain syndromes where on-going motor dysfunction, in the absence of pain, may 
predispose to symptom persistence or recurrence. 
Keywords: Corticomotor output; Experimental muscle pain; Motor activity; Recovery; 
Transcranial magnetic stimulation.  
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INTRODUCTION 
When acute muscle pain is present, intracortical inhibition in the primary motor cortex (M1) is 
increased (1) and corticomotor output to the painful muscle is reduced (2). These changes are 
thought to reflect an adaptive motor strategy that restricts movement of the painful part and protects 
the area from further pain, damage or threat thereof (3). However, a perplexing finding from 
previous work is that altered intracortical activity and reduced corticomotor output persist after pain 
has resolved (2). These data suggest that although pain may provide a salient cue for rapid 
reorganization of the motor system, the removal of pain is insufficient to trigger a return to normal 
motor output.  
The factors that trigger a return to normal motor output following the resolution of acute 
muscle pain are unknown. However, studies investigating motor output following an episode of 
acute muscle pain are usually conducted with the affected limb at rest (2). One possibility is that 
resumption of normal motor activity in the post-pain period is required to facilitate a return to 
normal motor output. Motor activity including motor learning (e.g. 5-finger sequence task) (4), 
motor practice (e.g. racquet sports, violin players) (4), skill (e.g. visuomotor tracking task) and 
strength training  (e.g. biceps curls at one repetition max synchronized to an auditory cue) (5, 6), 
and even movement observation (7), is known to increase corticomotor output and reduce 
intracortical inhibition; such effects could counteract the changes observed following acute muscle 
pain. Evidence for a relationship between motor activity and recovery of corticomotor output can 
also be drawn from studies that have examined the effect of pain on motor learning. For example, 
when task performance is controlled (i.e. feedback is provided to ensure the same task is performed 
with and without pain), corticomotor output is reportedly unchanged in response to acute muscle 
pain and the characteristic increase in corticomotor output observed with motor learning is 
abolished, suggesting the two effects may cancel each other (8, 9). Despite this, no study has 
examined the impact of motor activity on the magnitude and duration of reduced corticomotor 
output following acute muscle pain.  
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The present study aimed to examine the effect of motor activity, undertaken immediately 
following the resolution of acute muscle pain, on the magnitude and duration of altered 
corticomotor output following experimental muscle pain. It was hypothesized that motor activity 
would promote recovery of corticomotor output (reduced magnitude and duration of corticomotor 
depression) in the 30 minutes following resolution of acute muscle pain when compared with a 
condition where the painful limb remained at rest.  
 
 
METHODS 
 
Participants 
Twenty, healthy, right-handed individuals volunteered to participate and were randomly allocated to 
either the Rest (4 male, 6 female; 27 ± 6 years, mean ± SD) or Movement (4 male, 6 female; 27 ± 6 
years) group. Participants completed a transcranial magnetic stimulation (TMS) safety screen (10) 
prior to commencement and had no history of musculoskeletal, neurological or upper limb 
conditions. All subjects received written and verbal description of experimental procedures and 
provided written informed consent consistent in line with the Declaration of Helsinki. Experimental 
procedures were approved by the local human research ethics committee (N-20130055). 
 
Experimental protocol 
In both the Rest and Movement groups, fifteen motor evoked potentials (MEPs) were recorded from 
the right extensor carpi radialis brevis (ECRB) muscle at baseline, immediately following the 
resolution of experimental muscle pain (prior to the movement task in this group) and at 10, 20, and 
30 minutes follow-up (Figure 1). In the Rest group, participants sat quietly, without moving for the 
duration of the experiment. Particular emphasis was given to keeping the right arm completely still 
and relaxed at all times. Participants in the Movement group were asked to repeat a right-sided 
unimanual pattern of five sequential keystrokes as quickly and as accurately as possible in two 3-
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minute blocks, with 1-minute rest between blocks (11). Using the numbered keys from ‘2’ to ‘5’ on 
a standard keyboard, participants were asked to repeat the sequence ‘3-5-2-4-3’ using their right 
hand. The sequence was provided on a computer screen placed in front of each participant. Previous 
studies have mapped the long finger and extensor muscles following a similar 5-finger sequence 
task and have shown an increase in corticomotor excitability in both muscle groups (12). The 
Movement task was completed immediately following the resolution of experimental muscle pain 
and prior to recording of the 10-minute follow-up measures.  
 
Electromyography recordings 
Electromyographic (EMG) activity was recorded from the right ECRB muscle using silver/silver 
chloride surface electrodes (Medicotest 720-01-K, Ambu A/S, Ballerup, Denmark) positioned over 
the muscle belly according to previous protocols (13). EMG signals were sampled at 2 kHz and 
bandpass filtered at 20 Hz–1 kHz (EM006-01, SMI, Aalborg, Denmark). The EMG was further 
digitized by a 16-bit data-acquisition card (National Instruments, NI6122) and saved by custom-
made Labview software (Mr Kick, Aalborg University). 
 
Transcranial magnetic stimulation 
Single pulse TMS was delivered using a Magstim 200 stimulator (Magstim Co. LtD, Dyfed, UK) 
and a figure-of-eight coil. The coil was positioned over the left hemisphere at a 45-degree angle to 
the sagittal plane for each participant to preferentially induce current in a posterior-to-anterior 
direction. The optimal cortical site (‘hotspot’) to evoke responses in right ECRB, defined as the coil 
position that evoked a maximal peak-to-peak MEP for a given stimulation intensity, was 
determined and marked on the scalp. Stimulator intensity was set to evoke a peak-to-peak MEP of 
approximately 0.5 mV in the relaxed ECRB muscle at baseline. This intensity was kept constant 
throughout the experiment. Peak-to-peak MEP amplitude was measured and averaged across trials 
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for each participant at each time-point. All TMS procedures adhered to the TMS checklist for 
methodological quality (14). 
 
Experimental muscle pain 
The site for injection of the right ECRB muscle was determined using real-time ultrasound imaging 
and the skin was cleaned with alcohol. Pain was induced into the muscle by a bolus injection of 0.5 
ml sterile hypertonic saline (5.8 %) using a 1-ml syringe with a disposable needle (27G) (15). Pain 
was recorded every 30 seconds using an 11-point numerical rating scale (NRS) anchored with ‘no 
pain’ at zero and ‘worst pain imaginable’ at 10, immediately following injection of hypertonic 
saline injection until the pain returned to zero. Muscle pain was considered resolved when a 
participant reported a pain score of 0/10 on the NRS. To capture the characteristics and distribution 
of pain, the McGill pain questionnaire was administered at the end of each experiment together with 
pain drawings.  
 
Data and statistical analyses 
A two-way analysis of variance (ANOVA) was used to compare differences between (Rest vs. 
Movement) and within (baseline, immediately post pain, 10, 20 and 30 minutes follow-up) groups 
over time. Normality was assessed using the Shapiro-Wilk test. MEP amplitude required log 
transformation to meet assumptions of normality. Where appropriate, post-hoc analyses were 
performed using Holm-Sidak multiple comparison tests. Peak pain NRS scores, pain duration, and 
TMS stimulator output required to evoke a MEP of approximately 0.5 mV at baseline in ECRB, 
were compared between groups (Rest vs. Movement) using t-tests. Linear regression was performed 
to examine associations between the magnitude of the MEP depression and peak pain and duration 
in both groups. All data in text are presented as mean ± standard deviation (SD). Statistical 
significance was set at P<0.05. 
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RESULTS 
Experimental pain profile 
Peak pain intensity (NRS scores) following injection of hypertonic saline was 7.5 ±1.6 in the Rest 
group and 6.2 ± 1.7 in the Movement group (F1.18=3.2, P<0.09, Figure 2). The average pain 
duration was 8.2 ± 3.6 min for the Rest group and 6.5 ±1.6 min for the Movement group (F1.18=1.7, 
P<0.20, Figure 2). The words most commonly used to describe pain in response to injection of 
hypertonic saline on the McGill pain questionnaire in both groups were cramping (75 % of 
participants), heavy (75 %), aching (70%), sharp (60 %), and tiring/exhausting (40 %).  
 
Recovery of corticomotor excitability is not influenced by motor activity 
The average stimulator output required to evoke a MEP of approximately 0.5 mV peak-to-peak 
amplitude in right ECRB was 53.6 ± 8.9 in the Rest group and 49.5 ± 9.5 in the Movement group 
(F1.18=0.98, P<0.33). MEP amplitude was reduced in both groups (effect of time F4.72=4.6, P<0.002; 
Figure 3) at 10 min (post-hoc: P<0.002), 20 min (post-hoc: P<0.02), and 30 min (post-hoc: 
P<0.037) following the resolution of pain relative to baseline. MEP amplitude was not reduced 
immediately following pain compared with baseline (post-hoc: P<0.33). However, this was due to 
two individuals who showed initial facilitation at this time-point in the Movement group (Figure 4A 
and B). Excluding these subjects from the MEP analysis did not reveal a difference between the 
Rest and Movement groups (F1.64=0.23, P<0.63). There was no difference in the magnitude of MEP 
depression immediately following resolution of muscle pain based on gender when the two 
individuals who showed large facilitatory responses (both male) were removed (Male: -31 ± 18 %; 
Female: mean -27 ±  27 %). There was no association between the magnitude of MEP depression 
and peak pain or pain duration in either group (Rest: peak pain r=0.068, p=0.85; duration r=0.45, 
p=0.19; Movement: peak pain r=0.21, p=0.56; r=0.09, p=0.81). 
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DISCUSSION 
Contrary to the hypothesis, performance of motor activity immediately following the resolution of 
acute muscle pain did not alter the magnitude or duration of corticomotor depression. These data 
suggest that a return to normal corticomotor output following pain: i) may depend on motor activity 
of a type or duration not examined here or that is delivered earlier than the post-pain period (i.e. 
immediately before or during pain), ii) may rely on cues other than motor activity (e.g. removal of 
threat), or iii) is reliant on the resolution of neurophysiological mechanisms that are time dependent. 
Understanding corticomotor depression in the post-pain period and what factors promote recovery 
has relevance for clinical pain where on-going motor dysfunction, in the absence of pain, may 
predispose to symptom persistence or recurrence. 
A recent meta-analysis demonstrates a moderate reduction in corticomotor output, measured 
using TMS, during acute muscle pain when motor evoked potentials (MEPs) are elicited with the 
target muscle at rest but not under active contraction (2). Moreover, a strong reduction in 
corticomotor output in the post-pain period (0-30 minutes after the resolution of pain) was 
demonstrated when MEPs are elicited both at rest and under active contraction (2). Thus, 
corticomotor output is suppressed in the post-pain period and this effect appears to: i) persist for at 
least 30 minutes following pain (most studies cease recording at this time-point regardless of return 
to normal motor output), ii) be stronger than that which is present during muscle pain, and iii) be 
unaffected by the amount of motor activity required to measure MEPs under active contraction. The 
reason for maintained suppression of corticomotor output once pain has resolved is unclear. 
However, it has been hypothesized that suppression persists in the post-pain period as a defense 
against the threat of further pain and injury (16). Importantly, it has also been hypothesized that 
reduced corticomotor output that persists once pain has resolved in clinical populations could lead 
to sustained changes in movement patterns that alter loading on surrounding tissues, decrease 
movement variability, and predispose to persistent or recurrence of pain (16). As a result, 
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understanding the factors that promote a return to normal corticomotor output could have relevance 
in the treatment and prevention of musculoskeletal pain. 
 Counteracting the suppression of corticomotor output with motor activity is one strategy that 
could reduce the magnitude or duration of corticomotor suppression following acute muscle pain. 
Motor activity in a variety of forms has been repeatedly shown to increase corticomotor output in 
target muscles and adjacent task-related muscles (4). Indeed, a previous study using a similar 5-
finger sequence task showed an increase in corticomotor excitability of the long finger flexors and 
extensors using TMS (12). It is therefore surprising that motor activity immediately following the 
resolution of pain in the current study had no effect on the magnitude or duration of corticomotor 
suppression. There are several possible explanations for this lack of effect. First, it is possible that a 
motor intervention may need to be delivered earlier (i.e. immediately preceding or during pain) to 
interfere with the development of corticomotor suppression. This is supported by data from studies 
that examined the effect of motor learning on pain and showed no change in corticomotor output 
(i.e. an absence of the characteristic decrease in corticomotor output expected with pain and an 
absence of the characteristic increase expected with motor learning, suggesting effects are cancelled 
out) when the task was performed during pain (8, 9). Similarly, a particular type of motor activity 
(e.g. motor learning, motor control, strength), specifically targeted to the painful muscle, may be 
required. Future studies should explore the optimal timeframe and type of motor intervention that 
best promotes a return to normal corticomotor output following pain. This information is important 
given that general advice to stay active is provided in most clinical guidelines for the management 
of acute clinical pain, yet it is unknown what type, how much or precisely when, motor activity 
should be adopted to improve clinical outcomes. 
 A second explanation for our findings is that motor activity does not provide a sufficient 
trigger for return to normal corticomotor output. It is possible that other factors, such as removal of 
threat, the stress response or psychosocial determinants are more important in driving the return to 
normal output. Indeed, these factors are known to correlate with recovery of function in some 
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people with clinical musculoskeletal pain 
e.g.
(17-19). However, this possibility has yet to be 
explored in response to acute muscle pain. 
 Finally, it is plausible that recovery of corticomotor output following acute muscle pain is 
related to time-dependent neurophysiological mechanisms. For example, it has recently been shown 
that circuits involved in sensorimotor integration (short-and long-latency afferent inhibition) exhibit 
less inhibition in response to acute muscle pain, but only once pain has resolved (20). These 
mechanisms are hypothesized to contribute to recovery of corticomotor output following pain. 
Eventual recovery may reflect a balance between the mechanisms involved in recovery (20) and 
those involved in generating a protective motor strategy (reduced corticomotor output) (1), causing 
corticomotor suppression to persist early after the resolution of pain. If this is the case, interventions 
that enhance the excitability of networks involved in sensorimotor integration may be more 
effective at promoting recovery following acute muscle pain.  
This study has several limitations. First, data was collected on a relatively small sample. 
Although it is possible our sample was underpowered to detect an effect between groups, the data 
showed no evidence of a trend for an effect of group on corticomotor output over time (P<0.97). 
Second, a vehicle control was not included. Vehicle controls are commonly used in experimental 
pain studies and rarely, if ever, show an effect (21, 22). For example, previous studies of similar 
methodology have demonstrated no effect of intramuscular isotonic saline solution on the amplitude 
or latency of MEPs from upper limb muscles (23, 24). Further, corticomotor output has been shown 
to be stable during 30 minutes of controlled, quiet sitting (25) and is reliable over short (0-4 days) 
and long (0-14 days, 0-1 months) intervals (26, 27). Taken together, these findings indicate that the 
measures used in this study to evaluate corticomotor output are not sensitive to time effects. Thus, 
our findings are unlikely to be replicated in a no-pain control condition. Finally, it is unknown how 
these findings may translate to other forms of pain such as acute inflammatory or cutaneous pain or 
in individuals who experience an acute exacerbation of a chronic musculoskeletal pain condition. 
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Future studies should seek to examine corticomotor excitability and motor activity in these pain 
populations. 
 
Conclusion 
This pilot study is the first to examine the effect of a motor task performed immediately following 
the resolution of acute muscle pain on the magnitude and duration of corticomotor suppression. 
These data suggest that this intervention does not affect corticomotor output in the 30 minutes 
following resolution of acute muscle pain. Future studies should seek to determine whether 
different motor interventions applied at different stages of pain (i.e. immediately before or during), 
or other external triggers, are more effective at promoting recovery of corticomotor output 
following pain. Such data may have relevance for the treatment and prevention of clinical pain 
syndromes where persistence of altered corticomotor output could underpin persistence and 
recurrence of pain.  
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FIGURE LEGENDS  
 
Figure 1. Experimental protocol for the Rest (top) and Movement (bottom) groups. A 1-minute rest 
period was applied between the two movement blocks in the Movement group.  
 
Figure 2. Mean of pain intensity rated on the 11-point numerical rating scale (NRS) every 30 s 
from the time of hypertonic saline injection into the right extensor carpi radialis brevis muscle until 
each participant reported 0 for the Rest (filled circles; +SD) and Movement (open circles; -SD) 
groups. 
 
Figure 3. Mean (+ SD) MEP amplitude at each time point in the Rest group (filled circles; -SD) 
and the Movement group (open circles; +SD). The grey box indicates the time of pain induced by 
hypertonic saline injection into the right extensor carpi radialis brevis muscle. Reduction in MEP 
amplitude from baseline (*, P < 0.05). 
 
Figure 4. MEP amplitude expressed as a proportion of baseline for each individual in the Rest (top) 
and Movement (bottom) group at each time-point. The grey box indicates the time of pain induced 
by hypertonic saline injection into the right extensor carpi radialis brevis muscle. Note that two 
participants in the Movement group exhibited facilitation immediately following the resolution of 
pain. 
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Experimental protocol for the Rest (top) and Movement (bottom) groups. A 1-minute rest period was applied 
between the two movement blocks in the Movement group.  
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Mean of pain intensity rated on the 11-point numerical rating scale (NRS) every 30 s from the time of 
hypertonic saline injection into the right extensor carpi radialis brevis muscle until each participant reported 
0 for the Rest (filled circles; +SD) and Movement (open circles; -SD) groups.  
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Mean (+ SD) MEP amplitude at each time point in the Rest group (filled circles; -SD) and the Movement 
group (open circles; +SD). The grey box indicates the time of pain induced by hypertonic saline injection 
into the right extensor carpi radialis brevis muscle. Reduction in MEP amplitude from baseline (*, P < 0.05). 
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MEP amplitude expressed as a proportion of baseline for each individual in the Rest (top) and Movement 
(bottom) group at each time-point. The grey box indicates the time of pain induced by hypertonic saline 
injection into the right extensor carpi radialis brevis muscle. Note that two participants in the Movement 
group exhibited facilitation immediately following the resolution of pain.  
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